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SUMMARY 
Cell-based studies of human ribonucleases traditionally rely on methods that deplete 
proteins slowly.  We engineered cells where the 3’5’ exoribonucleases of the exosome 
complex, DIS3 and EXOSC10, can be rapidly eliminated to assess their immediate roles in 
nuclear RNA biology.  Loss of DIS3 has the greatest impact, causing substantial accumulation 
of thousands of transcripts within 60 minutes.  These include: enhancer RNAs, promoter 
upstream transcripts (PROMPTs) and products of premature cleavage and polyadenylation 
(PCPA).  These transcripts are unaffected by rapid loss of EXOSC10, suggesting that they 
are rarely targeted to it.  More direct detection of EXOSC10-bound transcripts revealed its 
substrates to prominently include short 3’ extended ribosomal and small nucleolar RNAs.  
Finally, the 5’3’ exoribonuclease, XRN2, has little activity on exosome substrates, but its 
elimination uncovers different mechanisms for early termination of transcription from protein-
coding gene promoters.       
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INTRODUCTION  
The RNA exosome is a multi-subunit, 3’5’ exoribonuclease-containing complex 
originally discovered as important for ribosomal RNA (rRNA) processing (Mitchell et al., 1997). 
It also plays a crucial role in the turnover of multiple coding and non-coding (nc) transcript 
classes (Kilchert et al., 2016; Schmid and Jensen, 2018). Many of these transcripts, such as 
cryptic unstable transcripts (CUTs) in yeast or promoter upstream transcripts/upstream 
antisense RNAs (PROMPTs/uaRNAs) in humans, are products of antisense transcription 
(Flynn et al., 2011; Preker et al., 2008; Wyers et al., 2005). An additional class of ncRNA in 
humans, termed enhancer RNAs (eRNAs), are produced from divergent transcription at 
intergenic enhancer sequence elements. Like many other pervasive transcripts, eRNAs are 
highly sensitive to exosome degradation (Andersson et al., 2014).  More recently, products of 
premature cleavage and polyadenylation (PCPA) were also revealed as exosome substrates 
in mouse embryonic stem cells (Chiu et al., 2018). 
 The structure of the exosome is similar in yeast and humans and is composed of 9-11 
key protein subunits (Gerlach et al., 2018; Januszyk and Lima, 2014; Makino et al., 2013; 
Weick et al., 2018). It possesses a catalytically inactive barrel structure of 9-core subunits 
(EXO-9), arranged as a hexamer (the PH-like ring) capped with a trimeric S1/KH ring. EXO-9 
interacts with two 3’→5’ exoribonucleases: EXOSC10 (Rrp6 in budding yeast) and DIS3 (also 
known as Rrp44) (Makino et al., 2013). In budding yeast, DIS3 is present in both nuclear and 
cytoplasmic exosome complexes, but Rrp6 is only found in the nuclear complex (Allmang et 
al., 1999b). The composition of the exosome is more complicated in humans due to the 
presence of DIS3 subtypes; however the canonical DIS3 is predominantly found within the 
nucleoplasm (Tomecki et al., 2010). Similar to Rrp6, EXOSC10 is nuclear and is enriched 
within the nucleolus (Tomecki et al., 2010). While DIS3 and the core exosome components 
are essential in budding yeast, cells lacking Rrp6 are viable (Allmang et al., 1999b; Briggs et 
al., 1998).   
 EXOSC10 is a member of the RNase D family and contains a DEDD-Y active site 
providing distributive exoribonuclease activity (Januszyk et al., 2011). DIS3 is a processive 
ribonuclease related to the RNase II/R family, possessing an RNB and N-terminal PIN domain, 
and is capable of both exo- and endoribonuclease activity (Lebreton et al., 2008; Schneider et 
al., 2009). When interacting with the exosome complex Rrp6 is localised on top of the S1/KH 
cap, close to the entry pore leading into the central channel passing through EXO-9, whereas 
DIS3 is associated with the channel exit pore at the opposing pole of EXO-9 (Makino et al., 
2013; Wasmuth et al., 2014). Rrp6 can widen the entry pore leading into the central channel 
of EXO-9 facilitating threading of RNAs through EXO-9 towards DIS3 (Wasmuth et al., 2014). 
4 
 
RNA substrates entering the S1/KH cap can also be directed to the active site of Rrp6 for 
trimming and degradation.  Exosome activity is further enhanced by a range of co-factors, 
including the helicase, MTR4 (Lubas et al., 2011; Weick et al., 2018). 
Genome-wide characterisation of human exosome substrates have reported DIS3 as 
the main ribonuclease subunit responsible for degrading PROMPTs, prematurely terminated 
protein-coding transcripts and eRNAs (Szczepinska et al., 2015). The targets for EXOSC10 
in human cells are less well-characterised, but include rRNA precursors (Macias et al., 2015; 
Sloan et al., 2013).  In budding yeast, the active site of Rrp6 can aid processing of RNA 
substrates with more complex secondary structures, which is important during maturation of 
precursor rRNAs (Fromm et al., 2017).  The uncovering of previously unknown RNAs has also 
increased our understanding of transcriptional regulation.  For example, the discovery of 
PROMPTs helped to identify bi-directional transcription from most human promoters (Preker 
et al., 2008).  While our study was in progress, products of PCPA were found to be stabilised 
by exosome loss, indicating that a proportion of truncated protein-coding RNA precursors are 
degraded (Chiu et al., 2018).  This process is influenced by the recruitment of U1 snRNA to 
pre-mRNA and may constitute a transcriptional check-point.  Both PROMPTs and PCPA 
products frequently have poly(A) signals (PASs) at their 3’ ends and possess poly(A) tails 
when the exosome is depleted (Almada et al., 2013; Ntini et al., 2013).  As such, a PAS-
dependent mechanism is proposed for attenuating their transcription.  
Studies of the exosome complex in human cells usually involve protein depletion by 
RNA interference (RNAi), which is slow.  Advantages of rapid, versus slower, depletion include 
reduced opportunities for compensatory effects and an ability to identify the most acute 
substrates rather than more gradual accumulation of RNA over long time periods, which could 
be indirect.  This is also useful when inferring how frequently a process takes place, which is 
more difficult when protein depletion is over a period of days.  We engineered human cells for 
rapid, inducible degradation of EXOSC10 or DIS3.  Both catalytic components are essential 
but DIS3 degrades the majority of nuclear exosome substrates.  Direct detection of EXOSC10 
substrates revealed a role in snoRNAs maturation reminiscent of the situation in budding yeast 
(Allmang et al., 1999a).  Finally, the 5’3’ exonuclease, XRN2, showed little activity on any 
exosome substrate.  However, it promotes early termination of a subclass of transcription 
events from protein-coding genes suggesting a variety of such mechanisms.   
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RESULTS 
Depletion of EXOSC10 or DIS3 using the auxin-inducible degron system 
The auxin-inducible degron (AID) system allows rapid elimination of AID tagged 
proteins upon addition of auxin to cell culture media (Nishimura et al., 2009).  CRISPR/Cas9 
was used to C-terminally tag EXOSC10 or DIS3 with an AID (Figure 1A).  Hygromycin or 
neomycin resistance markers were incorporated into the cassettes for homology directed 
repair (HDR) so that bi-allelic modification could be selected for (Eaton et al., 2018).  A P2A 
site, between the AID and drug markers, ensured their separation via peptide cleavage during 
translation (Kim et al., 2011).  This system requires expression of the plant E3 ubiquitin ligase, 
Tir1, which we previously introduced stably into HCT116 cells - chosen for their diploid 
karyotype.   
Western blotting confirmed successful AID tagging of EXOSC10 as a species of the 
predicted molecular weight of EXOSC10-AID was detected in EXOSC10-AID cells with native-
sized protein absent (Figure 1B).  This was confirmed by the exclusive detection of native-
sized EXOSC10 in parental HCT116:TIR1 cells.  A time course of auxin addition demonstrated 
rapid depletion of EXOSC10-AID, which was reduced by ~97% after 60 minutes with native 
EXOSC10 insensitive to auxin.  Western blotting also showed the exclusive presence of DIS3-
AID in DIS3-AID cells and its depletion upon auxin treatment (Figure 1C).  DIS3-AID is 
expressed at lower levels than native DIS3 and quantitative reverse transcription and PCR 
(qRT-PCR) showed that there is a ~50% reduction in spliced DIS3-AID mRNA (Figure 1C).  A 
monoclonal antibody to the AID tag also detected DIS3-AID, which is absent from 
HCT116:TIR1 cells and eliminated within 60 mins of auxin treatment (Figure 1D).  Although 
DIS3-AID is expressed at lower levels than native DIS3, it does not limit the association of 
essential co-factors with the exosome core as we observed equal co-immunoprecipitation of 
EXOSC2 with GFP-MTR4 in DIS3-AID and parental cells (Figure 1E).  
To demonstrate the specificity of EXOSC10-AID and DIS3-AID depletion, we 
monitored the levels of several exosome components (EXOSC10, DIS3, EXOSC2, EXOSC3 
and MTR4) in parental, DIS3-AID and EXOSC10-AID cells treated or not with auxin (Figure 
1F).  Tagging EXOSC10 or DIS3 had no impact on the levels of other exosome factors in the 
absence of auxin.  Importantly, auxin treatment specifically eliminated the tagged factors 
without co-depleting other proteins. 
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Rapid depletion of EXOSC10-AID or DIS3-AID leads to accumulation of unstable RNAs 
We next tested the effects of eliminating EXOSC10-AID or DIS3-AID on some of their 
known substrates. To check for any adverse effects of auxin addition or the AID tag, we added 
the parental HCT116:TIR1 cells to the experimental series.  Depletion of EXOSC10 has been 
shown to stabilise a short 3’ extended version of the 5.8S rRNA (Allmang et al., 1999b; Briggs 
et al., 1998; Schilders et al., 2007).  We performed Northern blotting on total RNA isolated 
from EXOSC10-AID cells treated or not with auxin for 60 mins and probed blots for either 
mature or 3’ extended 5.8S rRNA (Figure 2A).  3’ extended 5.8S rRNA was weakly detected 
in treated and untreated HCT116:TIR1 cells and in untreated EXOSC10-AID cells. However, 
auxin treatment of EXOSC10-AID cells induced a strong increase in its levels.  As such, acute 
depletion of EXOSC10 is sufficient to reveal its RNA substrates with no apparent adverse 
effect of the AID tag. 
For DIS3, we analysed the levels of three PROMPTs (STK11IP, SERPINB8, and 
RBM39) and one anti-sense transcript (FOXP4-AS).  This was done in DIS3-AID cells treated 
or not with auxin (60 minutes) and in HCT116:TIR1 cells grown in the same conditions (Figure 
2B).  qRT-PCR showed no auxin-dependent changes in HCT116:TIR1 cells, as expected.  
PROMPT levels were similarly low in DIS3-AID cells untreated with auxin demonstrating that 
DIS3-AID is sufficient for their normal turnover.  However, auxin treatment of DIS3-AID cells 
results in a large increase in all cases confirming the effectiveness of this system.   
 
DIS3 and EXOSC10 are essential in human cells 
We next tested whether EXOSC10 and DIS3 are required for cell viability.  Colony 
formation assays were performed on EXOSC10-AID or DIS3-AID cells grown in the presence 
and absence of auxin and on HCT116:TIR1 cells under the same conditions.  HCT116:TIR1 
cells formed a similar number of colonies in the presence and absence of auxin demonstrating 
no adverse effects of auxin on viability (Figure 2C).  DIS3-AID cells formed as many colonies 
as HCT116:TIR1 cells when auxin was omitted, but their smaller size highlights a slight 
reduction in growth.  No DIS3-AID cell colonies formed in the presence of auxin showing that 
DIS3 is essential.  EXOSC10-AID cells showed no statistically significant defect in colony 
formation, in the absence of auxin, compared to HCT116:TIR1 cells (Figure 2D).  However, 
auxin prevented the formation of EXOSC10-AID cell colonies showing that EXOSC10 is 
essential.  This contrasts with budding yeast where ∆rrp6 cells are viable (Allmang et al., 
1999b).  
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Nuclear RNA-seq analysis following EXOSC10-AID or DIS3-AID elimination 
We next analysed the immediate impact of EXOSC10 and DIS3 loss more globally.  
Nuclear RNA was extracted from EXOSC10-AID or DIS3-AID cells that had been treated, or 
not, with auxin for one hour and performed RNA-seq.  Nuclear RNA was chosen as we 
anticipated most exosome substrates to be enriched in the nucleus.  We first analysed 
PROMPTs and found an obvious accumulation upon loss of DIS3 (Figure 3A).  Importantly, 
metagene analysis shows that PROMPTs accumulate at thousands of genes when DIS3 is 
absent (Figure 3B).  The global increase in PROMPT levels within just 60 mins of auxin 
treatment underscores their acute instability.  Further examination of the metaplot in Figure 
3B revealed no impact of either exosome subunit on the stability of 3’ flanking region RNA 
consistent with our finding that these species are XRN2 substrates (Eaton et al., 2018).  
Interestingly, acute depletion of EXOSC10 had no effect on PROMPT transcripts suggesting 
that they are not its immediate substrates.   
Hundreds of intergenic transcripts were also seen upon DIS3 elimination, which were 
barely detectable in the absence of auxin.  We presume that these are eRNAs because 
separating sequencing reads into sense and anti-sense strands showed their bi-directionality 
(Figure 3C).  Moreover, these regions have high H3K4me1 versus H3K4me3 modified 
chromatin at their promoter regions as do enhancers (Andersson et al., 2014; Core et al., 
2014; Heintzman et al., 2007) (Figures S1A and B).  Metagene analysis of these transcripts 
confirmed the generality of the DIS3 effect and, as with PROMPTs, show that they are 
generally not substrates for EXOSC10 (Figure 3D).  Our experiment again highlights the acute 
instability of eRNAs and straightforward uncovering of almost one thousand examples upon 
DIS3 loss.  This is a similar number to what has reported in other mammalian cells when the 
exosome was depleted over several days (Pefanis et al., 2015).  
Protein-coding promoters also produce a variety of exosome substrates in the sense 
direction, some of which are generated by PCPA (Chiu et al., 2018; Iasillo et al., 2017; Ogami 
et al., 2017).  Truncated pre-mRNA products are readily apparent in our data following rapid 
depletion of DIS3 but not when EXOSC10 is lost (Figure 3E).  A prominent example is 
observed for PCF11 pre-mRNA, which is subject to PCPA in mESCs (Chiu et al., 2018).  To 
test the generality of DIS3-mediated turnover of truncated pre-mRNAs we generated a 
metagene plot covering the first intron of genes (Figure 3F).  This showed an obvious 
enhancement of intron 1 levels in cells depleted of DIS3, with no effect of EXOSC10 loss 
observed.  This effect is still evident when intron read counts are normalised to those over the 
first exon but, importantly, is diminished over the second or fourth intron (Figures S1C-E).  The 
robust accumulation of such RNAs within minutes of DIS3 loss is an important observation 
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that underscores the high frequency of attenuated transcription.  All of the above DIS3 effects 
were confirmed in an independent biological RNA-seq replicate (Figure S2).  
 
There is little redundancy between EXOSC10 and DIS3 activity on nucleoplasmic 
PROMPTs 
A striking outcome of our RNA-seq data is the lack of EXOSC10 effect on the 
thousands of nucleoplasmic exosome substrates degraded by DIS3.  In contrast, depletion of 
EXOSC10 by RNAi often affects nucleoplasmic transcripts and co-depletion of EXOSC10 and 
DIS3 can produce synergistic effects that imply some redundancy (Lubas et al., 2011; Tomecki 
et al., 2010).  To analyse EXOSC10 effects on nucleoplasmic substrates more closely, we 
performed a more extended time course of auxin treatment (4 h and 8 h) in EXOSC10-AID or 
DIS3-AID cell followed by quantitation of SEPHS1, RBM39 and PPM1G PROMPTs (Figure 
4A).  Whilst DIS3-AID loss increases the levels of all three transcripts, none were significantly 
affected by the absence of EXOSC10-AID.  Interestingly, MTR4 associates with the exosome 
core whether or not EXOSC10-AID is present supporting the existence of functional 
complexes even when EXOSC10 is absent (Figure 4B).  We next treated EXOSC10-AID cells 
for 24, 48 or 72 h with auxin, which revealed a mild increase in PROMPTs at longer time points 
(Figure 4C).  As EXOSC10 effects require long-term protein depletion, this could be due to 
indirect consequences of its loss or reflective of very occasional roles in PROMPT turnover.  
This is not an indirect effect of auxin as PROMPT levels were unaffected in parental cells after 
72 h of treatment (Figure 4D).     
The absence of acute EXOSC10 effects on PROMPTs argues that DIS3 degrades 
them in its absence.  To test this, DIS3-AID cells were transfected with control or EXOSC10-
specific siRNAs before treatment or not with auxin.  qRT-PCR was then used to analyse the 
levels of SEPHS1, RBM39 and PPM1G PROMPTs (Figure 4E).  DIS3 elimination from control 
siRNA treated cells caused upregulation of each PROMPT as expected.  For RBM39 this 
effect was generally not as large as in Figure 2B, which may result from the additional 
perturbation caused by RNAi.  EXOSC10 depletion caused an increase in PROMPT levels 
even in the presence of DIS3-AID, which is consistent with the small effect of EXOSC10-AID 
loss at long time-points of auxin treatment.  Importantly, auxin treatment of EXOSC10-
depleted DIS3-AID cells revealed a larger enhancement of PROMPT levels than depletion of 
either protein alone.  As such, although EXOSC10 plays little role in PROMPT RNA 
degradation under normal circumstances, its presence may be more important when DIS3 
levels are very low.    
DIS3 loss disrupts focused nucleolar localisation of EXOSC10  
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To understand why low DIS3 levels may lead to degradation of some nucleoplasmic 
exosome substrates by EXOSC10 we monitored its localisation in DIS3-AID cells treated or 
not with auxin over a time course (Figure 4F).  As previously reported (Lubas et al., 2011; 
Tomecki et al., 2010), EXOSC10 is nucleolar enriched as shown by co-localisation with 
nucleolin.  Strikingly, DIS3-AID loss resulted in less focussed nucleolar localisation of 
EXOSC10 (also see Figure S3A).  This was not due to a breakdown of nucleoli as nucleolin 
signal showed little alteration in the same cells.  Furthermore, at extended time points of DIS3-
AID loss, we observed nucleoplasmic puncta of EXOSC10 in ~25% of cells that do not overlap 
with nucleolin signal.  Importantly, EXOSC10 localisation in DIS3-AID cells is identical to the 
parental cell line and analysis of wider fields of cells confirmed the generality of the effects 
(Figures S3B-C).  We conclude that DIS3-AID loss disrupts the normally focussed nucleolar 
localisation of EXOSC10, which may allow it to engage with nucleoplasmic substrates and 
potentially explain the synergistic effect of EXOSC10 and DIS3 co-depletion on PROMPTs. 
 
EXOSC10 is involved in 3’ trimming of pre-rRNA and pre-snoRNA transcripts 
We next wanted to identify specific substrates of EXOSC10 and utilised individual-
nucleotide resolution UV crosslinking and immunoprecipitation (iCLIP) to detect transcripts 
that it directly binds to.  We complemented previous iCLIP data, generated using functional 
EXOSC10 (EXOSC10WT) in HEK293T cells (Macias et al., 2015), with iCLIP using a 
catalytically dead version of EXOSC10 (EXOSC10CAT) also expressed in HEK293T cells.  
EXOSC10CAT contains a single substitution (D313N) previously shown to abolish EXOSC10 
activity (Januszyk et al., 2011).  We reasoned that EXOSC10CAT would associate more stably 
with EXOSC10 substrates and facilitate their detection.   
As EXOSC10 loss leads to accumulation of 3’ extended 5.8S rRNA (Figure 2A), we 
validated our iCLIP data by first assessing this potential substrate.  There was strong iCLIP 
signal specifically at this site in EXOSC10CAT samples, which had 33 fold more reads mapping 
within a 30nt window downstream of 5.8S than EXOSC10WT (Figure 5A). This large read 
density seen in EXOSC10CAT indicates the catalytic mutant is blocking processing of pre-5.8S 
and underscores it as a bone fide EXOSC10 substrate. Consistently, expression of inactive 
EXOSC10 in EXOSC10-AID cells enhances the levels of extended 5.8S RNA in dominant 
negative fashion (Figures S4A and B).  Read density rapidly drops beyond 30nts downstream 
of the annotated end of 5.8S rRNA, suggesting that EXOSC10 is only required for the final 
nuclear trimming step.  This indicates a ribonuclease switch and is consistent with re-
constituted 5.8S rRNA maturation in budding yeast, during which DIS3 processing is sterically 
inhibited by the exosome core necessitating handover to Rrp6 (Fromm et al., 2017; Makino et 
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al., 2015).  Interestingly, analysis of the entire 45S rDNA showed significant CLIP density over 
the 5’ETS in both EXOSC10WT and EXOSC10CAT (Figure S4C).  
We reasoned that the 30nt “footprint” downstream of the 5.8S rRNA, seen in 
EXOSC10CAT samples, can identify other RNAs subject to final processing by EXOSC10.  
Obvious ~30nt footprints of CLIP density were identified in 3’ flanking regions of snoRNAs with 
examples shown for SNORA69 and SNORD18C in Figure 5B.  Metagene analyses of the 
average distribution of EXOSC10 iCLIP reads over annotated snoRNAs indicates that 
EXOSC10 engages in processing of pre-snoRNAs that are extended at their 3’ ends by 
~30nts, due to the specific enrichment of CLIP density exclusively seen in the EXOSC10CAT 
iCLIP dataset (Figure 5C). Indeed, a majority of snoRNAs in both the SNORD and SNORA 
class showed this signature of EXOSC10CAT binding (Figure S5A).  Analysis of our RNA-seq 
data independently revealed examples where short extended snoRNA precursors are 
specifically stabilised by EXOSC10 loss (Figure 5D).  Overall, these data identify short 3’ 
extended RNA precursors as EXOSC10 substrates.  The implication of EXOSC10 in human 
snoRNA processing highlights conservation with budding yeast where Rrp6 performs a similar 
3’ trimming step (Allmang et al., 1999a).  We also noted examples where longer 3’ snoRNA 
extensions were seen on absence of DIS3 consistent with a ribonuclease handover and 
previous PAR-CLIP analysis (Szczepinska et al., 2015) (Figure S5B).  Finally, unlike for 3’ 
extended snoRNA and 5.8S rRNA, PROMPT and eRNA reads were not enriched in the 
EXOSC10CAT experiment and the exclusive expression of inactive EXOSC10 did not stabilise 
PROMPTs (Figures S5C and D).  This further demonstrates that they are not usually 
EXOSC10 substrates.     
 
Analysis of XRN2 regulation of exosome-targeted transcripts 
Transcripts can also be degraded from their 5’ end with XRN2 being the major nuclear 
5’3’ exoribonuclease and having a prominent role in transcriptional termination (Eaton et al., 
2018).  Although RNAi has also been used to study XRN2, it may not reveal its full repertoire 
of functions as we suggested previously by engineering XRN2-AID cells (Eaton et al., 2018).  
To more accurately assess the impact of XRN2 on PROMPT and eRNA degradation, we 
analysed our previously published nuclear RNA-seq from XRN2-AID cells in which XRN2 is 
eliminated within 60 mins of auxin treatment (Figure S6).  Interestingly, there was no general 
impact of XRN2 elimination on either of these transcript classes indicating that they are not its 
substrates.  
The termination of exosome substrates described here is poorly understood, but the 
XRN2-AID cell line allows assessment of its role in the process.  Accordingly, we analysed 
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PROMPT regions in mammalian native elongating transcript sequencing (mNET-seq) data 
that we previously generated in XRN2-AID cells (Eaton et al., 2018).  mNET-seq analyses the 
position of RNA polymerase at single-nucleotide resolution by sequencing the 3’ end of RNA 
from within its active site (Nojima et al., 2015).  Comparison of typical PROMPTs (MYC and 
RBM39) showed nascent transcription over these regions that terminated within ~1.5kb of the 
respective promoters (Figure 6A).  XRN2 elimination caused neither more reads over the 
termination region nor additional reads beyond it.  More general analysis of the XRN2 impact 
on PROMPT termination revealed only a very slight increase in signal at the 5’-most positions 
– also visible in the sense direction (Figure 6B).  Therefore, extended PROMPT transcription 
is not generally apparent in the absence of XRN2.  Consistently, RNA-seq revealed no general 
effect of XRN2 loss on PROMPT levels (Figures S6A and B). 
We also show that protein-coding genes produce exosome substrates in the sense 
direction (Figure 3E and F) and tested the impact of XRN2 on the termination of these 
products.  This analysis was performed on four truncated transcripts at the PIGV, PCF11, 
CLIP4 and SEPHS1 genes (Figure 3E demonstrates the DIS3 effect for PCF11 and PIGV with 
CLIP4 and SEPHS1 data in Figure 6C).  PCF11 was chosen as it is subject to PCPA in mESCs 
and has an annotated PCPA site in humans (Ensembl I.D: ENST00000624931.1; Chiu et al., 
2018) with the other three genes chosen at random.  As truncated transcripts overlap with full-
length transcription, we labelled nascent transcripts for 30 mins with 4 thiouridine (4sU) 
following treatment or not with auxin.  4sU labelled RNA was then captured via biotinylation 
and streptavidin beads, isolating it from material that pre-existed XRN2 elimination.  qRT-PCR 
was then performed using a primer pair within the DIS3-stabilised region (US) and another 
downstream of it (DS) (Figure 6D).  XRN2 loss induced a significant increase in RNA 
downstream of the DIS3-stabilised region for PIGV and PCF11, but not for SEPHS1 or CLIP4.   
Premature termination may constitute a dead end pathway or it could compete with 
full-length transcription.  To distinguish these possibilities, primers were designed to detect 
spliced PCF11, PIGV, CLIP4 or SEPHS1 mRNA in 4sU-labelled RNA isolated from XRN2-
AID cells treated or not with auxin (Figure 6E).  Primers were designed to detect spliced RNAs 
produced by transcription downstream of the attenuated transcript 3’ end (~26 kb in the case 
of PCF11).  Interestingly, XRN2 depletion significantly increased the level of spliced mRNA 
from PCF11 and PIGV suggesting that some transcripts escaping PCPA-mediated termination 
are not dead-end products.  However, spliced SEPHS1 or CLIP4 mRNA were unaffected by 
XRN2 loss in line with its lack of impact on their attenuated transcription.       
Finally, the apparent difference in sensitivity of early termination to XRN2 may be 
influenced by the frequency of attenuated transcription in each case.  To assess this, 
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attenuated SEPHS1, CLIP4, PIGV and PCF11 transcripts were assayed by qRT-PCR in DIS3-
AID cells treated or not with auxin (Figure 6F).  All four transcripts accumulated robustly on 
loss of DIS3 demonstrating similarly frequent attenuation of transcription with SEPHS1 
showing the largest effect.  As such, the insensitivity of SEPHS1 and CLIP4 early termination 
to XRN2 is not correlated with more infrequent attenuation of transcription compared to PCF11 
and PIGV.  We conclude that DIS3 is involved in the widespread degradation of attenuated 
transcripts from protein-coding genes which fall into subtly different classes.  We have 
distinguished some of these on the basis of their sensitivity to XRN2-dependent termination. 
 
DISCUSSION 
We have engineered conditional depletion of DIS3, EXOSC10 or XRN2 to assess their 
immediate impact on RNA metabolism. The rapid depletion achieved provides important 
insights that complement previous RNAi approaches.  Timescales of minutes, versus days, 
has the obvious advantage that transcripts are less likely to appear through secondary effects.  
Moreover, an accumulation of RNA within minutes demonstrates constant turnover in a way 
that is more difficult to infer by RNAi, during which accumulation may be gradual.  It also 
highlights acute substrates versus those that are only apparent after long periods of protein 
depletion as exemplified by EXOSC10s effect on PROMPT levels.  
We were initially concerned that the low levels of DIS3-AID may prove problematic for 
assaying the impact of its loss.  However, several observations mitigate this concern: first, 
although DIS3 is essential, DIS3-AID cells produce as many colonies as HCT116:TIR1 cells 
though they are smaller.  Second, DIS3-AID cells have the same levels of DIS3 substrates as 
HCT116:TIR1 cells when auxin is not used.  Third, DIS3 substrates do not accumulate upon 
rapid loss of EXOSC10 activity, underlining the specificity revealed by our approach.  Fourth, 
the level of other exosome components and the integrity of the exosome are not observably 
different between DIS3-AID cells and parental cells.     
While PROMPTs are stabilised by RNAi of EXOSC10 from DIS3-AID cells, no effect 
is observed when EXOSC10-AID is rapidly depleted even though bone fide substrates are 
stabilised at this early time-point.  Long-term auxin treatment of EXOSC10-AID cells does 
cause a mild increase in PROMPT levels suggesting that RNAi effects are due to prolonged 
EXOSC10 depletion.  This observation suggests that RNAs, such as PROMPTs, are only 
occasionally targeted by EXOSC10 or that their slight upregulation is an indirect effect of its 
long-term depletion.    A lack of effect of EXOSC10 on PROMPT (and eRNA) turnover is 
underscored by our iCLIP dataset, which showed that their recovery is not enhanced by 
inactivating EXOSC10 (Figure S5C).  Consistently, PROMPTs are not stabilised even when 
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EXOSC10 is catalytically inactive (Figure S5D).  These experiments demonstrate an evolving 
impact of EXOSC10 loss on transcript levels over time that may have an indirect explanation 
that should be considered when interpreting data from long-term depletion. 
Our experiments do show some role for EXOSC10 in PROMPT turnover when DIS3 
is lost as mis-localisation of EXOSC10 occurs when DIS3-AID is depleted and co-depletion of 
both proteins synergistically enhances PROMPT levels.  Given the nucleolar enrichment of 
EXOSC10, it may be lacking in a large fraction of nucleoplasmic exosome complexes 
explaining its limited impact on PROMPTs and other DIS3 substrates.  Reciprocally, DIS3 
shows relative exclusion from nucleoli, raising the possibility of compartment-specific catalytic 
complexes (Tomecki et al., 2010).  Consistently, we show that EXOSC10 is not required for 
MTR4 to associate with the exosome core as judged by its continued immunoprecipitation with 
EXOSC2 in auxin treated EXOSC10-AID cells.  This is resonant with recent structural data 
demonstrating MTR4 to contact the human exosome via MPP6 and EXOSC2 and explains 
how lack of EXOSC10 is compatible with continued degradation of transcripts by DIS3 (Weick 
et al., 2018).   
As it was initially difficult to identify EXOSC10 substrates from our RNA-seq data, we 
employed iCLIP to detect RNAs directly bound by EXOSC10.  This was facilitated by using 
the inactive protein, which revealed signatures of EXOSC10 binding more robustly than the 
wild type protein.  There was an obvious predominance of short (~30 nts) extended precursors 
to 5.8S rRNA which we also saw by Northern blotting.  The sharp reduction of iCLIP reads 
beyond this 30nt footprint strongly suggests that EXOSC10 is involved in a final nuclear 
trimming step similar to what has been shown in budding yeast (Allmang et al., 1999a).  
Structural studies lend support to this hypothesis having shown that bulky RNA particles can 
become stalled at the entrance to the central channel of the exosome, necessitating a 
handover from Rrp44 to Rrp6 (Fromm et al., 2017; Schuller et al., 2018).  We suggest that 
handover is also required for human snoRNA processing because short extended snoRNAs 
are bound by EXOSC10 and stabilised upon its loss and because previous PAR-CLIP shows 
DIS3 association with longer snoRNA precursors (Szczepinska et al., 2015).  As snoRNAs are 
often present in introns of expressed genes, stabilised extensions may often be masked by 
host gene reads in RNA-seq with iCLIP providing a more direct assessment of their fate.  We 
would also like to note that the exosome may act redundantly with other snoRNA processing 
pathways in humans (Berndt et al., 2012).        
In studying the termination of exosome-sensitive RNAs emanating from protein-coding 
gene promoters, we found that PROMPTs and some truncated sense transcripts are 
insensitive to XRN2 loss.  Even so, many PROMPTs harbour PASs and poly(A) tails and 
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XRN2 is implicated in some anti-sense transcriptional termination by mNET-seq (Nojima et 
al., 2015).  However, the detection of poly(A) tails does not necessarily mean that 
polyadenylation occurs on every RNA in a population and it is possible that truncated sense 
transcripts are generated in multiple ways.  Indeed, a complex consisting of the cap-binding 
complex and ARS2 is implicated in the 3’ end processing and termination of short human 
transcripts including PROMPTs (Hallais et al., 2013; Iasillo et al., 2017).  At least some ARS2-
sensitive transcripts are generated by mechanisms that do not involve the canonical 
polyadenylation complex.  The differential XRN2 effect on PROMPT and truncated sense 
transcript termination also suggests a variety of promoter proximal termination processes.    
In sum, our data further highlight the constant and rapid turnover of thousands of 
transcripts in the human nucleus and identify specific substrates for DIS3, EXOSC10 and 
XRN2.  They also reveal that transcripts with apparently similar characteristics (e.g. PROMPTs 
and PCPA products) can be subtly distinguished on the basis of their sensitivity to XRN2.  We 
anticipate that the ability to rapidly control exoribonucleases, as we have done here, will be 
especially useful to interrogate processes that cannot be dissected by long term depletion.  
For example, to test the importance of short-lived RNAs and RNA turnover in stress responses 
or other changes in cellular environments.  
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FIGURE LEGENDS 
FIGURE 1.  Rapid depletion of EXOSC10 or DIS3 via the auxin-inducible degron 
(A) Schematic showing the CRISPR strategy for modifying gene loci.  Two repair cassettes 
were generated containing the AID tag, a P2A cleavage site and then either the hygromycin 
or neomycin resistance marker followed by an SV40 PAS.  These were flanked by 5’ and 3’ 
homology arms for the gene of interest.   
(B) Western blotting of EXOSC10 in either parental Tir1-expressing HCT116 (HCT116:TIR1) 
or EXOSC10-AID cells.  A time course of auxin addition was applied to the EXOSC10-AID 
cells.  Equal loading is shown by the presence of a non-specific product (*) on the same blot. 
(C) Western blotting of DIS3 in either HCT116:TIR1 or DIS3-AID cells treated or not for 60 
minutes with auxin.  Tubulin was probed for as a loading control.  qRT-PCR-derived levels of 
DIS3 mRNA also shown (including standard deviation) obtained following normalisation to 
GAPDH levels. 
(D) Western blotting of DIS3 in either HCT116:TIR1 or DIS3-AID cells treated or not for 60 
minutes with auxin using an antibody to the AID tag.  Tubulin was probed for as a loading 
control. 
(E) Co-immunoprecipitation (Co-IP) of GFP-MTR4 and EXOSC2 in HCT116:TIR1 or DIS3-
AID cells.  Input (5%) and IP are shown.  Blots were probed with α-GFP (to detect GFP-MTR4) 
or α-EXOSC2.   
(F) Western blotting of EXOSC10, DIS3, MTR4, EXOSC2, EXOSC3 and, as loading control, 
CPSF73 in HCT116:TRI1, DIS3-AID or EXOSC10-AID cells treated or not with auxin (1h).  
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Due to the similar size of some of these proteins, multiple blots were probed rather than 
employing stripping.  Equal loading was confirmed by loading control/ponceau.  Pictures of 
individual blots are deposited at Mendeley (see methods). 
 
FIGURE 2. Effects of DIS3/EXOSC10 depletion on RNA substrates and cell viability 
(A) Northern blot analysis of mature (lower panel) and 3’ extended (upper panel) 5.8S rRNA 
performed in HCT116:TIR1 cells and EXOSC10-AID cells treated or not with auxin.  Bar graph 
shows quantitation expressed as a ratio of extended to mature species. n=3. * denotes p<0.05.  
Error bars are standard deviation. 
(B) qRT-PCR detection of STK11IP, SERPINB8, FOXP4-AS and RBM39 PROMPTs in 
HCT116:TIR1 cells and DIS3-AID cells treated or not with auxin (1h).  Quantitation is 
expressed as relative RNA level relative to that found in non-auxin treated HCT116:TIR1 cells 
after normalising to ACTB RNA. n=3. * denotes p<0.05.  Error bars are standard deviation. 
(C) Colony formation assay for HCT116:TIR1 cells and DIS3-AID cells grown with or without 
auxin.  Number of colonies expressed as a percentage of those forming from HCT116:TIR1 
cells grown in the absence of auxin. Values show average and standard deviation from n=3. 
(D) As for (C) but for HCT116:TIR1 and EXOSC10-AID cells. 
 
FIGURE 3.  Global analysis of the effects of EXOSC10 or DIS3 loss 
(A) Integrative genome viewer (IGV) browser tracks of MARS2, PPM1G and SEPHS1 
PROMPT transcripts (boxed) in EXOSC10-AID and DIS3-AID cells treated or not with auxin. 
Y-axis units are reads per kilobase per million mapped (RPKM).   
(B) Metagene plot of coding and non-coding genes in EXOSC10-AID and DIS3-AID cells 
treated or not with auxin.  DIS3 loss shows a strong effect on PROMPT regions (boxed).   
(C) IGV browser tracks of two eRNA regions in EXOSC10-AID and DIS3-AID cells treated or 
not with auxin. Y-axis units are RPKM.   
(D) Metagene plot of all eRNA expressing regions in EXOSC10-AID and DIS3-AID cells 
treated or not with auxin.   
(E) IGV browser tracks of PCF11 and PIGV in EXOSC10-AID and DIS3-AID cells treated or 
not with auxin.  Both show strong upregulation of 5’ pre-mRNA upon loss of DIS3 (boxed).  Y-
axis units are RPKM.  
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(F) Metagene plot of all first introns in EXOSC10-AID and DIS3-AID cells treated or not with 
auxin.   
 
FIGURE 4.  Analysis of redundancy between EXOSC10 and DIS3 
(A) qRT-PCR analysis of PPM1G, SEPHS1 and RBM39 PROMPTs in DIS3-AID or EXOSC10-
AID cells treated or not with auxin for 4 and 8 h.  Levels are expressed as fold change 
compared to untreated cells (indicated by dotted line) following normalisation to GAPDH 
mRNA. n=3. * denotes p<0.05 for differences concluded on in the text.  Error bars show 
standard deviation. 
(B) Co-immunoprecipitation of EXOSC10 or EXOSC2 with GFP-MTR4 in EXOSC10-AID cells 
treated or not with auxin (2 h).  Input and IP are shown with blots probed with α-GFP (to detect 
GFP-MTR4), α-EXOSC10 or α-EXOSC2.   
(C) qRT-PCR analysis of PPM1G, SEPHS1 and RBM39 PROMPTs in EXOSC10-AID cells 
treated or not with auxin for 24, 48 or 72h.  Levels are expressed as fold change compared to 
untreated cells (indicated by dotted line) following normalisation to GAPDH mRNA. n=3. * 
denotes p<0.05 for differences concluded on in the text.  Error bars show standard deviation. 
(D) qRT-PCR analysis of PPM1G, SEPHS1 and RBM39 PROMPTs in HCT116:TIR1 cells 
treated or not with auxin for 72h.  Levels are expressed as fold change compared to untreated 
cells (indicated by dotted line) following normalisation to GAPDH mRNA. n=3. Error bars show 
standard deviation. 
(E) qRT-PCR analysis of PPM1G, SEPHS1 and RBM39 PROMPTs in DIS3-AID cells 
transfected with control or EXOSC10-specific siRNAs before treatment, or not, with auxin (1h).  
Levels are expressed as fold change compared to control siRNA transfected cells untreated 
with auxin following normalisation to GAPDH mRNA. n=4. * denotes p<0.05 for differences 
concluded on in the text.  Error bars show standard deviation. 
(F) EXOSC10 immunofluorescence in untreated DIS3-AID cells or the same cells treated with 
auxin for 1, 2, 3 or 4 h.  The same cells stained with nucleolin are also shown.  The red arrows 
show EXOSC10 puncta that do not overlap with nucleolin signal. 
 
FIGURE 5.  Direct detection of EXOSC10 substrates by iCLIP 
(A) iCLIP trace of 5.8S rRNA locus obtained from EXOSC10WT and EXOSC10CAT samples.  
There is a clear enrichment of reads for the EXOSC10CAT sample showing a 30 nucleotide 
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“footprint” immediately beyond the 5.8S gene (indicated by vertical lines).  Y-axis units are 
reads per million mapped. 
(B) iCLIP traces of SNORA69 and SNORD18C genes obtained from EXOSC10WT and 
EXOSC10CAT samples.  There is strong enrichment of reads for the EXOSC10CAT sample 
showing a 30 nucleotide “footprint” immediately beyond each gene.  Y-axis units are reads 
per million mapped. 
(C) Metagene plots of iCLIP reads over the 5’ or 3’ regions of snoRNA genes in EXOSC10WT 
and EXOSC10CAT samples.  There is a clear 30 nucleotide “footprint” immediately 3’ of 
snoRNA genes. 
(D) IGV browser tracks of SNORA48 and SNORA68 genes in EXOSC10-AID and DIS3-AID 
cells treated or not with auxin.  These show upregulation of short 3’ extended versions of each 
(boxed) in auxin-treated EXOSC10-AID cells. Y-axis units are RPKM. 
 
FIGURE 6.  Effects of rapid XRN2 loss on exosome substrates and early transcriptional 
termination 
(A) MYC and RBM39 PROMPT region tracks in mNET-seq data obtained from XRN2-AID 
cells treated or not with auxin.  y-axes show signals per 108 mapped reads. 
(B) Metagene analysis of PROMPT regions (boxed) in mNET-seq data obtained from XRN2-
AID cells treated or not with auxin. TPM denotes transcripts per million. Signal below zero on 
the y-axis represents antisense PROMPT transcription. 
(C) Gene tracks of CLIP4 and SEPHS1 attenuated transcription in EXOSC10-AID or DIS3-
AID cells treated or not with auxin (1 hr).  Truncated RNAs stabilised by DIS3 loss are boxed.  
Y-axis shows RPKM. 
(D) qRT-PCR analysis of premature transcriptional termination at PCF11, PIGV, CLIP4 and 
SEPHS1 genes in 4sU-labeled RNA from XRN2-AID cells treated or not with auxin (1h).  A 
gene track for PCF11 shows DIS3-stabilised products together with approximate primer 
positions.  Red arrow denotes annotated PCF11 PCPA product.  The same primer position 
principles apply to the other three genes tested.  Graph shows quantitation where values are 
plotted relative to those in untreated XRN2-AID cells following normalisation to spliced GAPDH 
mRNA levels. n≥3. * denotes p<0.05.  Error bars show standard deviation. 
(E) qRT-PCR analysis of spliced PCF11, PIGV, CLIP4 and SEPHS1 mRNA in 4sU-labeled 
RNA extracted from XRN2-AID cells treated or not with auxin (1h).  Graph shows quantitation 
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where values are plotted relative to those in untreated XRN2-AID cells following normalisation 
to spliced GAPDH mRNA levels. n≥3.  * denotes p<0.05.  Error bars show standard deviation. 
(F) qRT-PCR quantitation of the DIS3 effect on truncated PCF11, PIGV, CLIP4 and SEPHS1 
transcripts determined in DIS3-AID cells treated or not with auxin (1h).  Graph shows 
quantitation where values are plotted relative to those in untreated DIS3-AID cells following 
normalisation to spliced GAPDH mRNA levels. n≥3.  Error bars show standard deviation.   
 
STAR METHODS 
KEY REAGENTS AND RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
AID  MBL Cat# M214-3 
EXOSC10 (Fig1 B)  abcam Cat# Ab50558 
EXOSC10 (other figures) Santa Cruz Cat# Sc-374595-X 
DIS3 Bethyl DIS3  Cat# A303-765A 
Nucleolin  abcam Cat# Ab22758 
MTR4 Bethyl Cat# A300-614A 
GFP abcam Cat# ab290 
EXOSC3 abcam Cat# ab156683 
MYC Santa Cruz Cat# sc-40 
Mouse Alexa Flour 555  Invitrogen Cat# A-21424 
Rabbit Alexa Fluor 488 Invitrogen Cat# A-11034 
CPSF73 abcam Cat# ab131245 
EXOSC2 abcam Cat# ab181211 
Tubulin abcam Cat# ab7291 
Anti-FLAG® M2 Magnetic Beads Sigma Cat# M8823-1ML 
Chemicals, Peptides, and Recombinant Proteins 
Auxin Sigma Cat# I3750-5G-A 
Benzonase Sigma Cat# E1014-5KU 
Critical Commercial Assays 
Plasmid mini-prep kit Qiagen Cat# 27106 
Gibson assembly mastermix (for cloning) NEB Cat# E5510S 
GFP-Trap beads Chromotek Cat# Gtma-20 
QuikChange II XL Site-Directed Mutagenesis Kit Stratagene Cat# 200521 
QIAquick nucleotide removal kit Qiagen Cat# 28304 
Deposited Data 
Sequencing data EXOSC10 and DIS3 Gene Expression 
Omnibus 
GSE120574 
Sequencing data XRN2 Gene Expression 
Omnibus 
GSE109003 
Uncropped blots Mendeley https://data.mendele
y.com/datasets/jyh2
wdyb7z 
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EXOSC10 WT iCLIP Biological replicate 1 & 2 (Macias et al., 2015); 
Gene Expression 
Omnibus 
GSM1892061 & 
GSM1892062 
EXOSC10 CAT iCLIP data Gene Expression 
Omnibus 
GSE120574 
H3K27ac ChIP-seq  Gene Expression 
Omnibus 
GSE31755 
H3K4me1 ChIP-seq Gene Expression 
Omnibus 
GSE31755 
H3K4me3 ChIP-seq Gene Expression 
Omnibus 
GSE35583 
ChIP input control Gene Expression 
Omnibus 
GSE31755 
Experimental Models: Cell Lines 
HCT116:TIR1 (Eaton et al., 2018) N/A 
DI3-AID This paper N/A 
EXOSC10-AID This paper N/A 
XRN2-AID (Eaton et al., 2018) N/A 
EXOSC10-AID + EXOSC10 CAT This paper N/A 
EXOSC10-AID + EXOSC10 WT This paper N/A 
Oligonucleotides 
Control siRNA Thermofisher Cat# AM4613 
EXOSC10 siRNA Thermofisher Silencer select: 
S10738 
qPCR primers This paper Supplemental 
material 
iCLIP Oligo: L3 3’ RNA adapter: 5’Phosphate-
UGAGAUCGGAAGAGCGGUUCAG-3’Puromycin  
(Konig et al., 2010) N/A 
iCLIP Oligo: rtCLIP_5: 5’Phosphate-
NNCGCCNNNAGATCGGAAGAGCGTCGTGgatcCTGA
ACCGC 
(Konig et al., 2011) N/A 
iCLIP Oligo: Cut_oligo: 
GTTCAGGATCCACGACGCTCTTCaaaa 
(Konig et al., 2011) N/A 
iCLIP Oligo: P5Solexa : 
AATGATACGGCGACCACCGAGATCTACACTCTTTCC
CTACACGACGCTCTTCCGATCT 
(Konig et al., 2011) N/A 
iCLIP Oligo: P3Solexa : 
CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCA
TTCCTGCTGAACCGCTCTTCCGATC 
(Konig et al., 2011) N/A 
5.8S Northern probe:  GCAAGTGCGTTCGAAGTGT This paper N/A 
5.8S 3’ EXT Northern probe: 
GGGGCGATTGATCGGCAA 
This paper N/A 
Primer pairs for qRT-PCR This paper Table S1 
Recombinant DNA 
px330 for CRISPR (Cong et al., 2013) Addgene Cat# 
42230 
GFP-MTR4 (Lubas et al., 2011) 
A kind gift from the lab 
of Torben Jensen 
N/A 
Plasmids for DIS3 tagging This paper Critical sequences in 
Supplemental 
material 
Plasmids for EXOSC10 tagging This paper Critical sequences in 
supplemental 
material 
EXOSC10WT for iCLIP This paper and 
(Macias et al., 2015) 
N/A 
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EXOSC10CAT for iCLIP This paper N/A 
EXOSC10WT for Figures S4A, 7B,  This paper N/A 
EXOSC10CAT for Figures S4A, 7B This paper N/A 
Software and Algorithms 
pyCRAC (Webb et al., 2014) N/A 
TopHat2 (Kim et al., 2013) N/A 
BEDTools (Quinlan and Hall, 
2010) 
N/A 
Image J (colony counting and image processing)  N/A 
MACS2 (Zhang et al., 2008) N/A 
deeptools (Ramirez et al., 2014) N/A 
featureCounts (Liao et al., 2014) N/A 
DESeq2 (Love et al., 2014) N/A 
StringTie (Pertea et al., 2016) N/A 
SortMeRNA (Kopylova et al., 2012) N/A 
HISAT2 (Kim et al., 2015) N/A 
SAMTools (Li et al., 2009) http://samtools.sourc
eforge.net/ 
Other 
eRNA & PROMPT annotations (Chen et al., 2016) N/A 
 
CONTACT FOR REAGENT AND RESOURCE SHARING 
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Steven West (s.west@exeter.ac.uk). 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Experiments involved human colon carcinoma derived HCT116 cells (male) and human 
embryonic kidney derived HEK293T cells (female). 
METHOD DETAILS 
Cell culture and cell lines 
HCT116 and HEK293T were cultured in Dulbecco modified eagle medium with 10% 
foetal calf serum.  Our CRISPR protocol and plasmids was described previously (Eaton et al., 
2018).  Sequences of EXOSC10 and DIS3 homology arms are provided in this manuscript.  
Briefly, HCT116 cells grown on a 30mm dish were transfected with 1ug each of guide RNA 
plasmid, Neomycin and Hygromycin repair constructs.  Transfection was with Jetprime 
(Polyplus) following the manufacturers’ guidelines.  Media was changed after 24 hours and, 
after 72 hours, cells were re-plated into 100mm dishes in media containing 30ug/ml 
Hygromycin and 800ug/ml Neomycin.  Resistant colonies were picked and screened by PCR 
10-14 days later.  Correct genomic insertion of tags was assayed by sequencing these PCR 
products.  Auxin was used at a concentration of 500uM for one hour unless stated otherwise.  
For RNAi, 24-well dishes were transfected with siRNA using Lipofectamine RNAiMax (Life 
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Technologies) following the manufacturers’ guidelines.  The transfection was repeated 24 
hours later and, 72 hours after the first transfection, RNA was isolated. 
 
qRT-PCR and 4sU analysis 
In general 1ug of RNA was isolated using Tri-reagent and DNAse treated for one hour 
before reverse transcription (Protoscript II) using random hexamers.  cDNA products were 
diluted to 50ul volumes.  1ul was used for real-time PCR in a Qiagen Rotorgene instrument 
using Brilliant III SYBR mix (Agilent technologies).  The comparative quantitation option in the 
software was used to generate graphs.  The 4sU qRT-PCR protocol is as described in Eaton 
et al 2018. 
Immunofluoresence 
Cells were grown on cover slips, treated for 0, 1, 2, 3, or 4 hours with auxin, washed 
with PBS, fixed for 10 minutes in 4 % PFA, washed with PBS, permeabilised with 0.1 % Triton 
x-100 (v/v in PBS) for 10 minutes, then blocked with 10 % FBS (v/v in PBS) for 1 Hour. Cells 
were probed overnight with 1:1000 diluted α-EXOSC10 and α-nucleolin at 4 °C, washed with 
0.01 % NP40 (v/v in PBS), probed with Alexa Fluor® 488 anti-rabbit and Alexa Fluor® 555 
anti-mouse secondary’s (1:2000, Invitrogen) for 1 hour, counter stained with DAPI, washed 
and mounted. All images were taken using an Olympus-81 oil immersion microscope, 
exposure times, brightness and contrast settings are identical between images. 
 
Nuclear RNA-seq 
 Nuclei were extracted using hypotonic lysis buffer (10 mM Tris pH5.5, 10 mM NaCl, 
2.5 mM MgCl2, 0.5% NP40) with a 10% sucrose cushion and RNA was isolated using Tri-
reagent. Following DNase treatment, RNA was Phenol Chloroform extracted and ethanol 
precipitated.  After assaying quality control using a Tapestation (Agilent), 1 µg RNA was rRNA-
depleted using Ribo-Zero Gold rRNA removal kit (Illumina) then cleaned and purified using 
RNAClean XP Beads (Beckman Coulter). Libraries were prepared using TruSeq Stranded 
Total RNA Library Prep Kit (Illumina) and purified using Ampure XP beads (Beckman Coulter). 
A final Tapestation D100 screen was used to determine cDNA fragment size and 
concentration before pooling and sequencing using Hiseq2500 (Illumina) at The University of 
Exeter sequencing service.  GEO accession numbers: (EXOSC10-AID and DIS3-AID cell 
RNA-seq: GSE120574), (XRN2-AID cell RNA-seq: GSE109003). 
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RNA-Seq Read Alignment 
Raw single-end 50bp reads were screened for sequencing quality using FastQC; 
adapter sequences were removed using Trim Galore! and trimmed reads shorter than 20 bp 
were discarded. All nuclear RNA-seq analyses were carried out using the Ensembl 
GRCh38.p10 and GRCh38.90 human gene annotations. Before alignment, trimmed reads 
were passed through the SortMeRNA pipeline (Kopylova et al., 2012) to remove trace rRNA 
matching in-built 18S and 28S human databases then mapped to GRCh38 using HISAT2 (Kim 
et al., 2015) with default parameters supplemented with known splice sites. Unmapped, 
multimapped and low MAPQ reads (< 20) were discarded from the final alignment using 
SAMtools (Li et al., 2009). 
 
de novo Transcript Assembly 
de novo transcripts were assembled from each library using the StringTie suite (Pertea 
et al., 2016) with default parameters, guided by current GRCh38 reference annotation. Known 
annotated genes were dropped and the assembled transcripts from each sample were merged 
into a single consensus annotation. Reads were then counted per transcript using 
featureCounts (Liao et al., 2013, 2014) and differentially expressed upregulated de novo gene 
intervals (≥ 2-fold, padj < 0.05) were called using DESeq2 (Love et al., 2014). de novo 
transcripts were designated as a PROMPT (<3 kb) or eRNA (> 3 kb) based on their relative 
distance from the nearest annotated gene.  
 
Generation of Synthetic Intron Annotation 
A custom intron annotation file was produced from GRCh38 by merging all exon 
intervals derived from each transcript isoform to generate a synthetic transcript representative 
of every gene.  Each synthetic exon was then subtracted from gene intervals using the 
BEDtools suite (Quinlan and Hall, 2010) producing intron intervals with inherited gene 
information. Synthetic introns were counted and numbered according to their strand 
orientation i.e. sense introns numbered ascending, antisense introns descending, finally 
merging into a single annotation file. 
 
Meta Profiling 
PROMPT and eRNA Analysis 
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For metagene analysis, expressed protein-coding and ncRNA genes (> 50 reads per 
gene) were selected and an extended transcriptional window was then applied to each gene 
to include a 3 kb region 5’ of the TSS and a 7 kb region 3’ of the TES. Overlapping genes and 
genes that extended beyond chromosome ends were discarded using the BEDtools suite to 
prevent double read counting. Profiles of these filtered genes were then generated from RPKM 
normalised reads using deeptools (Ramirez et al., 2014) with further graphical processing 
performed in the R environment (http://www.R-project.org). Normalised coverage plots 
(RPKM) were visualised using the Integrative Genome Viewer (IGV) suite. For eRNA meta 
profiles, no extended window was applied and plots were generated directly from RPKM 
normalised reads and the de novo eRNA annotation file. 
 
Peak Calling from ChIP-seq Analysis 
ChIP-Seq data was generated by ENCODE from immunoprecipitation (IP) of 
acetylated histone 3 lysine 27 (H3K27ac) (GEO: GSE31755), monomethylated histone 3 
lysine 4 (H3K4me1) (GEO: GSE31755), trimethylated histone 3 lysine 4 (H3K4me3) (GEO: 
GSE35583) and an input control sample (GEO: GSE31755) in unmodified HCT116 cells. Raw 
single-end ChIP-seq reads were processed to remove adapter sequences and low quality 
reads then mapped to GRCh38 using spliced alignment disabled HISAT2 parameters. BAM 
alignment files were converted to BED and duplicate reads were discarded and collapsed into 
a coverage BEDGRAPH file. Peaks were called using MACS2 (Zhang et al., 2008). A 
background ChIP-Seq signal calculated from the input control sample was compared against 
each histone modification after sequencing depth normalisation, generating a set of peaks for 
each mark. Peaks were then passed through a Poisson test to call peaks with a qvalue cut-
off < 0.05 producing coverage files of peak enrichment. Enrichment of H3K4me1 and 
H3K4me3 marks were compared and visualised as a log2 ratio using deeptools. 
 
Northern Blot Analysis 
Total RNA was separated on a 12% Urea-PAGE gel, transferred on to a Hybond-N+ 
nylon membrane (GE Healthcare), dried and UV crosslinked (2 x 1200 µjoules/cm2) before 
blocking in hybridisation buffer (6x SSPE [150 mM NaCl, 9 mM NaH2PO4, 1 mM EDTA (pH to 
7.4], 5x Denhardt’s Reagent, 0.2% SDS) at 37°C for 1 hour. DNA probes were 5’ radiolabelled 
with [γ-32P]ATP using T4 PNK (NEB) and cleaned with Qiagen QIAquick nucleotide removal 
kit. Probes were then added to the hybridisation buffer and incubated at 42°C overnight. 
Membranes were then rinsed in hybridisation buffer 3 times for 1 minute then washed at 42°C 
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for 15 minutes before drying and developing on a Phosphor screen. Images were developed 
on a GE Typhoon FLA 7000 (GE Healthcare). Developed images were then quantitated and 
analysed using the ImageJ suite. Membranes were probed with the 5.8S 3’ ext probe first 
before stripping and re-probing with the mature 5.8S probe. 
 
Colony Formation Assay 
Cells were seeded into 100 mm cell culture plates and grown in auxin or ethanol 
(solvent) for 10 days. Growth media and auxin were replaced every 2-3 days. Colonies were 
fixed in ice cold methanol for 10 minutes and stained using 0.5% (w/v) crystal violet + 25% 
(v/v) methanol for 10 minutes. Stained colonies were counted using the ImageJ particle 
analyser function. Genuine colonies were defined as existing at a density ranging between 
50-8000 pixels with a circularity rating between 0.75-1 (1 = perfect circle). 
 
iCLIP - Experimental 
3xFLAG-EXOSC10CAT was generated from 3xFLAG-EXOSC10WT using Quick-change site-
directed mutagenesis kit (Stratagene) to introduce a single amino acid change from Aspartic 
acid to Asparagine (D313N) within the conserved DEDD-Y motif rendering EXOSC10 
catalytically inactive. HEK293T cells were seeded into 15cm plates and transiently transfected 
with 3xFLAG-EXOSC10CAT and collected 48hrs later when 90% cell confluency was reached. 
Cells were crosslinked twice on ice using 120 mJ/cm2 UVC irradiation, with ice cold PBS 
replaced after each cross-linking phase. iCLIP was performed on these cell pellets based on 
the protocol outlined in (Konig et al., 2011). FLAG-tagged proteins were purified using M2 
FLAG Dynabeads. A RNA linker (5′Phosphate-UGAGAUCGGAAGAGCGGTTCAG-
3′Puromycin) was ligated to the 3′ end of RNAs, which was described in Konig et al (Konig et 
al., 2010). Libraries were sequenced using the Illumina HiSeq system (Bejing Genomics 
Institute).  
 
iCLIP - Computational  
Reads were demultiplexed, processed and PCR duplicates were collapsed using 
Flexbar (Dodt et al., 2012), FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/), and 
custom perl scripts, respectively.  Biological replicates were combined to increase coverage. 
Reads were mapped to either Hg38 or a consensus sequence for 45S rDNA using Tophat 
with the --max-multihits 1 option called. Genome browser files were normalised to reads per 
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million mapped. Average distribution plots for snoRNAs were generated using 
pyReadCounters.py and pyBinCollector.py from the pyCRAC software package (Webb et al., 
2014). iCLIP data for 3xFLAG-EXOSC10WT was obtained from (Macias et al., 2015; 
GSM1892061 and GSM1892062) and analysed in parallel with EXOSC10CAT data 
(GSE120574). SnoRNA table was generated by identifying any snoRNA that had an 
EXOSC10 iCLIP read mapped within 50nt downstream of the 3’ end of a mature snoRNA.  
PROMPT and eRNA annotations were derived from (Chen et al., 2016). 
 
mNET-seq 
 The mNET-seq experiment and analyses pipeline are as previously published in 
(Eaton et al., 2018).  The XRN2-AID data are deposited with Gene Expression Omnibus 
(GSE109003).   
 
Co-immunoprecipitation 
Approximately 5 million cells were transfected with 5µg of GFP-MTR4 plasmid and the 
following day, lysed in IP lysis buffer (150mM NaCl, 2.5mM MgCl2, 20mM Tris.HCl pH7.5, 1% 
Triton X-100) by incubation on ice for 30 mins with 1µl of Benzonase.  Lysates were clarified 
by centrifugation (12000rpm for 10 mins) and then incubated with 20µl GFP-TRAP beads 
(Chromotek) for 1 hour at 4oC with rotation.  Beads were washed four times with IP lysis buffer 
and complexes eluted in 2x SDS gel loading buffer for analysis by western blotting. 
 
EXOSC10 HDR 5’ 
TTGATCCTCCCGCCTTGGCCTCCCAGAGTACTGGGATTACAGGTGTGAGCCACTGCAC
CCAGCCAAATGTTTTTGTTAAAAACATAAAATCCTAATAATTAAGCCGACCCTGAGGTCA
GGGGACTTGCCCGAGGGCAGGAAAAACAGGTCTGCCTTCTCAAGATGCTGCTCAGCTC
AGCCAACTCTGGTGGGCCGCCGAGTTCTCTGGGGCCCCTGAGCAAACCATTCTTCCTC
TGTTCTGCATGATTAAGATTTGCACCATTTTGTAAACCATCTGAGAACATCCAACCAGCC
CGGAAGAAATAACTGTTGTTTTTGTACTCTCTGCAGAGGCTTCAGGTACAACTGGCCAC
AGAGA 
EXOSC10 HDR 3’ 
TAGTCCTGGAAGACACGTGGCGCCTGTGGACCGGAAGCACCAAATGCTGGTGCTGCTT
TTGTACATACATATTTTTAAACCATTAAAATTCTTCCTGAAGAAAGCTGATTCCTGACTTT
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TATTTTGTTGCCGCCACAGCTCTGGCAGGTTGCCATCCTGTTCAGGCAACCATCTTCAG
CTGTCTGTGGGCAGGTGAGTGTGCTCCGGGGGTTATGGTGACTTCTAGAAAAATCCAG
AGCCGGCCGGGTGCGGTGGCTCACGCCTGCAATCCCAGCACTTTGGGAGGCTGAGGC
AGGCGGATCACGAGGTCAGGAGATCGAGACCATGCTGGCCAACACGGTGAAAGC 
EXOSC10 gRNA target: AGATAGTCCTGGAAGACACG 
DIS3 HDR 5’ 
CTTGAAATCAACTCTGATTCTGTCAATCACAGTGGCTCCCCATTGGGAAGGCTGTTTTG
TAGTTAAAAAGAACACTTCCTAAATGACATGCTTCTCACCTGTTGAGACCATGTCTAGCT
TTTACATTTTTGAACCACTGCTACTTTGTAAAATACCTTCTGTGTATAAAACCTTTAATTA
GCCCCCTTTCCCCTCCCTACCACTACATCCTTTTAAATTTGAAGCTGGCAGTGGGGAAG
GGGAGGATGAGGTTGAGATGTATTCTATCCTTTAAATCACCTTATTTCCCCCCATTTGCA
TTACTTTAGATACCAGGAATAAGCATTCCTACAGACACATCTAACATGGACCTTAATGGA
CCAAAGAAAAAGAAGATGAAGCTTGGAAAA 
DIS3 HDR 3’ 
TAGCTATATTCAACAAAAATCTTCAAAGACTGGTTTCTTTTTTAAAAGAAAAAACTTGAAA
GAACACTTCTAAGCCTAAGTGTGTGATACAGTTTGTTACTTTTAAGTACATTTTAATAATT
TCAGACATCTGCATTTTTATTGAACAGTTGACTGTATCTGACCCATCATACTACTATACTT
CTGGGTTGAACAGAATTATTTATGCAGAATAATTCAATTGAATATCCATCACTTAAATACA
GTGACAGGACAGCAACTTCAGGGATCTGTAAAGATCATTTAAATGGAGT 
DIS3 gRNA target: ACTGATACTTCAAACATGGA 
Codon optimised IAA17 (AID) 
GGTAGTGGCATGATGGGTAGTGTGGAGCTGAACCTGCGCGAGACCGAGCTGTGCTTG
GGACTGCCTGGCGGCGATACGGTTGCACCCGTTACCGGGAACAAGAGGGGCTTCAGC
GAGACAGTGGATCTCAAGCTGAATCTGAACAACGAACCTGCAAATAAAGAGGGAAGCA
CCACTCATGACGTAGTGACATTCGATAGTAAAGAGAAATCTGCTTGCCCGAAGGATCCA
GCTAAGCCCCCGGCCAAGGCCCAGGTGGTGGGATGGCCCCCGGTGCGCTCCTACCG
CAAAAACGTGATGGTATCATGCCAGAAAAGCAGCGGGGGGCCCGAAGCCGCCGCTTTT
GTTAAAGTGTCAATGGACGGGGCTCCATACCTGAGGAAGATCGATCTCCGGATGTACA
AGTCTTACGATGAACTGAGCAACGCGCTTTCAAACATGTTCTCATCTTTCACCATGGGA
AAGCATGGGGGCGAAGAAGGAATGATTGACTTCATGAATGAGAGAAAACTGATGGATC
TCGTCAATTCTTGGGACTACGTGCCTTCATACGAGGATAAGGATGGAGATTGGATGCTG
GTAGGAGACGTGCCTTGGCCCATGTTCGTGGACACTTGCAAAAGGCTCAGACTGATGA
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AGGGTAGCGATGCCATCGGCTTGGCACCCCGCGCGATGGAGAAGTGTAAATCTAGGG
CC 
Table S1: oligonucleotides used for qRT-PCR, STAR METHODS 
Amplicon Forward Reverse 
PIGV US AAGGGGTTGTTGGGAAGTGA CCACTTGACCATGCTTGCAT 
PIGV DS AGTTCAGGGCTTCACAGTGA CTCAGGCCTCTAAACCCCAA 
PCF11 US TGACCATTCTAGCCGAGGAG 
GGGGTTGGAGAGAAGGAAC
A 
PCF11 DS CACACTGGCTCTGCACAAAT CACACGAACATGCAGGAAGT 
PIGV SPL GACCCTAGAGAAGCCCGATC CTCAACAGCGGCTCTTGATC 
PCF11 SPL TGAAGAAGAGGAGGAATGGCA GGGTTCCTGCAATTCGTTTT 
GAPDH SPL GCACCACCAACTGCTTAGC ATGATGTTCTGGAGAGCCCC 
ACTB SPL CATCCGCAAAGACCTGTACG CCTGCTTGCTGATCCACATC 
PPM1G GCCTGGCCAAGTACTTCCTA CCTCTTCCTTCGTTCCCAGT 
STK11IP GGGAGTCTAAGGAAAAGGAG 
CAGTGAAAGGAGAGCGTAT
C 
SERPINB8 ACCAAGCAAAGGAGTCAGGA ACGTCCACCCAAACATTCTC 
RBM39 GGAAATAGTGGAGAAAAGCA CATTTTTGAAGGAACGGTAG 
FOXP4-AS TGCACAATTTCACACCTAGA ATGTTAGTGACACCTGCACA 
SEPHS1 
PROMPT TCTCCACATTTCACGAGGCT 
ATTTGCACAGGAGGCTAGGA 
DIS3 SPL 
ACCCTCACTTAAAATAGAAGATAC
AGT 
CCATTAAGGTCCATGTTTGA
AGT 
CLIP4 SPL ATTTTCTGCTTCTGATACCCCA CCCACTGTCTCAAAATGGCA 
CLIP4 US GTCAGGCTGTTCACGTCATC TTTCAAAGGCGCCCGTTTTA 
CLIP4 DS TCCTTTGTTTGGAAGATACCCA 
GGCGTAACAGAGAAGTCAA
GT 
SEPHS1 SPL GGAAACATGTTCGGCCTCAT CTATGATTCTGGCTGTGCGG 
SEPHS1 US TGAGCGCCTTCCTGATACAA TTTAACACAGCCTCACCCCT 
SEPHS1 DS GGTGTCATGTGAACCTGCAG CTGCCAGCGAATCAAGTGAA 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
qRT-PCR was quantitated using the comparative quantitation function associated with the 
Qiagen Rotorgene instrument.  Values were first normalised to ACTB or GAPDH and then 
samples were compared by quantitating the experimental values relative to the control 
condition (given the value of 1 by the software).  Bars show the average of at least three 
replicates and error bars show the standard deviation.  Where assessed, p values were 
calculated using a student’s t-test. 
 
DATA AND SOFTWARE AVAILABILITY 
All sequencing data, generated in this study, are deposited with Gene Expression Omnibus.  
We also analysed data deposited previously.  Accession numbers are: XRN2-AID data 
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(GSE109003); DIS3-AID RNA-seq, EXOSC10-AID RNA-seq and EXOSC10CAT iCLIP 
(GSE120574); EXOSC10WT iCLIP (GSM1892061 & GSM1892062); H3K27ac ChIP-seq 
(GEO: GSE31755); H3K4me1 ChIP-seq (GEO: GSE31755), H3K4me3 ChIP-seq (GEO: 
GSE35583); ChIP input control (GEO: GSE31755). 
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Supplemental Text and Figures
Figure S1: Further analysis of eRNA regions and pre-mRNA stability in EXOSC10-AID and DIS3-AID cells, 
related to Figure 3
(A) Examples of eRNA stabilised upon DIS3 loss.  These regions show bi-directional transcription (red and blue are 
signals from opposite strands) and a high level of H3K4me1 versus H3K4me3 characteristic of eRNA transcription.  Y-
axis shows RPKM for RNA-seq.  Lower panel of each figure shows H3K4me1 (blue) vs H3K4me3 (red).  H3K4me1 
density shown above the line with H3K4me3 below.  
(B) Two protein-coding genes shown for comparison with part A.  In this case, promoter regions are associated with low 
H3K4me1 but higher levels of H3K4me3.  Scales are as for A.  Both eRNA and protein-coding promoters show 
H3K27ac modification.
(C) Metagene showing enhanced reads over the first intron of genes upon auxin treatment of DIS3-AID cell lines.  
Unlike main text Figure 3F, this representation shows the intron reads normalised to read density in the upstream first 
exon which was also higher in auxin treated samples possibly because of the general stabilisation of truncated RNAs.  
For auxin treated DIS3-AID samples, read-density was therefore normalised to the average difference in exonic read-
density compared to untreated samples. Finally, both exon and intron metagene profiles were merged into a single 
profile demarcated by a dotted line.  R1 and R2 corresponds to different biological replicates of each experiment.
(D) Metagene showing RNA-seq reads across the second intron of genes in EXOSC10-AID and DIS3-AID cells treated 
or not with auxin.  The effect of DIS3 loss is diminished relative to the first introns.  The plot is not normalised to exon 1 
and generated as for Figure 3F.
(E) As for A, but for intron 4.  Note, that the effect of DIS3 loss is near absent by this stage in transcription.  The plot is 
not normalised to exon 1 and generated as for Figure 3F.
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Figure S2: Biological replicate of DIS3-AID and EXOSC10-AID RNA-seq, related to Figure 3
This figure is the same as main text figure 3 except the data are derived from a second biological repeat of the RNA-seq.  
Accordingly, annotations are the same as for main-text figure 3.
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Figure S3: Analysis of EXOSC10 localisation in HCT116:TIR1 and DIS3-AID cells treated or not with auxin, 
related to Figure 4F)
(A) Immunofluorescence experiment whereby HCT116:TIR1 or DIS3-AID cells grown in the presence or absence of 
auxin (1 hr) are stained for EXOSC10 or nucleolin.  This representation is an enlarged view (of a different cell for 
DIS3-AID to highlight generality) compared to Figure 4F used to further illustrate that DIS3 loss affects EXOSC10 
staining in the nucleoli of DIS3-AID cells.  In contrast, auxin treatment of parental (HCT116:TIR1) cells does not 
impact on EXOSC10 nucleolar staining. 
(B) Immunofluorescence experiment whereby HCT116:TIR1 cells grown in the presence or absence of auxin are 
stained for EXOSC10 or nucleolin.  This experiment confirms the nucleolar location of EXOSC10 and that auxin 
treatment does not affect this.
(C) A wider field of DIS3-AID cells representing the conditions shown in Figure 4F.  In each field, the individual cell 
used in Figure 4F is boxed.  Note that 24.6% of cells contain EXOSC10 puncta at the 4h time point (based on a 
random count of 191 cells, within 13 fields of view across replicates).
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Figure S4: Inactive EXOSC10 causes dominant negative stabilisation of rRNA precursors, related to Figure 
5
(A) Western blotting of EXOSC10 in EXOSC10-AID cells or EXOSC10-AID cells stably expressing either wild-
type (WT) or inactive EXOSC10 (CAT).  In each case, samples show cells treated or not with auxin (1h).  This 
demonstrates the selective depletion of only the AID tagged version.
(B) Northern blotting of the same cell lines and conditions in (A) whereby mature 5.8S rRNA (lower panel) or the 
3’ extended version (upper panel) were detected.  The 3’ extended version is also detected by the mature probe (*).  
Note that expression of inactive EXOSC10 has a dominant negative effect on the accumulation of the 3’ extended 
form, consistent with our iCLIP whereas expressing the WT protein has no such effect (compare lanes 1, 5 and 7).
(C) iCLIP track of 45S rRNA locus showing iCLIP read density obtained from EXOSC10WT or EXOSC10CAT.  
iCLIP reads are obtained across the whole locus but there is a striking accumulation of reads 3’ of the 5.8S gene in 
the EXOSC10CAT sample.  Units are reads per million mapped.  Lower track is zoomed to the 5’ETS sequence 
making it clear that there are sites of EXOSC10 binding, some of which are modestly enhanced in EXOSC10CAT
samples.  Units are reads per million mapped.
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Figure S5: Analysis of snoRNA 3’ extensions upon EXOSC10 or DIS3 loss, related to Figure 5
(A) Table summarising the percentage of expressed snoRNAs bound by either EXOSC10WT or EXOSC10CAT.
(B) IGV track of SNORA21 and SNORD13 in EXOSC10-AID and DIS3-AID cells treated or not with auxin.  
SNORA21 shows a longer 3’ extension when DIS3 is depleted and a shorter one when EXOSC10 is lost. 
SNORD13 also shows extended stabilisation upon loss of DIS3 and, more mildly, EXOSC10.  SNORD13 was the 
only example we found showing longer extensions in both cell lines.
(C) Table showing the proportion of iCLIP reads in the WT and CAT experiment that correspond to PROMPT, 
eRNA, 5’ flank of snoRNA, mature snoRNA or 3’ flank of snoRNA.  Also shown is the uplift (or not) in the 
proportion of reads as a result of using the inactive EXOSC10 (CAT/WT).  Bone fide substrates, exemplified by 3’ 
extended snoRNAs (red box), are more enriched in the CAT experiment.  However, PROMPTs and eRNAs are not 
enriched in this manner arguing that they are not normally EXOSC10 substrates – an observation supported by our 
RNA analyses.
(D) qRT-PCR analysis of PPM1G, SEPHS1 and RBM39 PROMPTs in EXOSC10-AID, EXOSC10-AID+WT or 
EXOSC10-AID+D313A cells treated or not with auxin (1h).  Values are shown relative to those obtained in 
untreated EXOSC10-AID cells after normalising to GAPDH levels.  Error bars are standard deviation.
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Figure S6: XRN2 plays no role in degrading PROMPT, eRNA or attenuated pre-mRNA, related to Figure 6
(A) MARS2 and SEPHS1 PROMPT regions in RNA-seq data obtained from XRN2-AID cells treated or not with auxin.
Note that there is a lack of XRN2 effect on PROMPT region RNAs (boxed) in both cases. “R1” and “R2” denotes two
biological replicates. Y-axis units are RPKM.
(B) Metaplot of promoter regions in RNA-seq data obtained from XRN2-AID cells treated or not with auxin. Note that
there is a general lack of XRN2 effect on PROMPT region RNAs consistent with our mNET-seq analyses in Figure 6.
(C) Tracks showing the same eRNA regions represented in Figure 3C in RNA-seq data obtained from XRN2-AID cells
treated or not with auxin. 8:8,290,610 shows no XRN2 effect. Whilst there is an enhanced anti-sense XRN2 effect for
X:45,705,862 this is due to a termination defect on a nearby micro RNA expressing gene and not due to eRNA
expression (part D of this figure). Note, that we have previously demonstrated that genes with 3’ microRNAs are subject
to XRN2-mediated termination (Eaton et al., 2018).
(D) IGV track of MIR222HG showing read-through transcription into the X:45,705,862 eRNA region (boxed) when
XRN2 is lost. This, not any role of XRN2 in eRNA stability, is responsible for the apparent increase in anti-sense signal
seen in part C of this figure. It is also consistent with our previous findings (Eaton et al., 2018) that XRN2 terminates
transcription following miRNA processing.
(D) Metaplot of eRNAs in RNA-seq data obtained from XRN2-AID cells treated or not with auxin. Note that there is a
general lack of XRN2 effect on eRNAs.
